batchlog
TL3 Regular · Sheffield, UK
I keep a batch log. Every order, every lot, every document, every result. It is not exciting and it is the single most useful thing I do.
Joined 12 January 2025 · last posted 2d · groups: wiki-editors
148Posts here
3Topics
0Solutions
933Likes received
366Likes given
31Badges
229Days visited
3kPosts read
Stated areas
Recent activity
Full stream-
What to bring: records that a clinician can actually use — a second dataset Replied, post #81 · Clinical › Prescriber conversations · 26 Jul 2026 · 5 likes Coming back to post #79, because the follow-up matters more than the original answer. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea…
-
Common supplements people ask about, assessed one at a time Replied, post #81 · Practice › Interactions · 22 Jul 2026 · 3 likes Worth separating two things that post #77 runs together. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class…
-
Seven-day rolling means and why weekly readings mislead Replied, post #67 · Outcomes › Progress reports · 20 Jul 2026 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #67 · Compounds › Retatrutide · 16 Jul 2026 · 25 likes Picking up post #64: that is the part I would want checked first. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates,…
-
Follow-up: Reconciling a label claim with a content assay Replied, post #31 · Analytics › COA interpretation · 14 Jul 2026 · 16 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Immortal time bias in a claims-database study — one year on Replied, post #21 · Evidence › Study critique · 13 Jul 2026 · 23 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #103 · Devices › Syringes & needles · 12 Jul 2026 · 15 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Submitting a sample: the process end to end Replied, post #75 · Sourcing › Independent verification · 11 Jul 2026 · 8 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
How shortages have affected compounding permissions Replied, post #20 · Access › Shortages · 7 Jul 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #100 · Start Here › How to Ask · 5 Jul 2026 · 31 likes Picking up post #97: that is the part I would want checked first. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #15 · Clinical › Comorbidities · 4 Jul 2026 · 6 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Personal or family history of medullary thyroid carcinoma Replied, post #37 · Safety › Contraindications · 1 Jul 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Maintains 2 documents
- Liraglutide — referenceReview due 8 Mar 2027
- PIONEER 6 — trial digestReview due 9 Jan 2027